TSMHT
PRCT icon

Thurston Springer Miller Herd & Titak’s Procept Biorobotics PRCT Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451 Hold
20
– – ﹤0.01% 1203
2026
Q1 		$500 Hold
20
– – ﹤0.01% 1285
2025
Q4 		$629 Buy
+20
New +$663 ﹤0.01% 1315
2025
Q3 		– Sell
-67
Closed -$3.86K – 1157
2025
Q2 		$3.86K Hold
67
– – ﹤0.01% 1329
2025
Q1 		$3.9K Sell
67
-5,558
-99% -$379K ﹤0.01% 1333
2024
Q4 		$453K Buy
+5,625
New +$481K 0.09% 187

Other funds holding PRCT

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
EA
Enclave Advisors Austin, Texas $790M AUM 21.99% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's PRCT Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 20 shares worth $451. The position accounts for ﹤0.01% of the portfolio, ranked #1203.

Thurston Springer Miller Herd & Titak first reported a position in PRCT in Q4 2024 and has held it in 6 quarters since. The position peaked at $453K in Q4 2024. 15 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 20 shares of Procept Biorobotics worth $451 as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1203 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Procept Biorobotics in Q4 2024 and has held it in 6 quarters since.
  • Thurston Springer Miller Herd & Titak's Procept Biorobotics position peaked at $453K in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.